Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2002, p. 3162-3166, Vol. 40, No. 9
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.9.3162-3166.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
School of Public Health, Division of Infectious Diseases, University of California at Berkeley, Berkeley, California 94720
Received 6 February 2002/ Returned for modification 18 May 2002/ Accepted 22 June 2002
|
|
|---|
|
|
|---|
The ability of M. tuberculosis to cause disease in the human or animal host may vary according to host susceptibility and to intrinsic biologic differences among clinical strains. The latter may reflect a particular strain's specific adaptation to the antimicrobial defenses of the host macrophage. For example, numerous studies have demonstrated that strains of Mycobacterium differ in susceptibility to reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) (7, 12, 16, 17, 18, 20, 23, 26).
The role of ROI and RNI in controlling acute infections with M. tuberculosis has been fairly well studied in the murine system (1, 3, 4, 8, 9, 10, 19). However, little is known about the role of these intermediates during latent infections. Studies have demonstrated that the inducible form of nitric oxide synthase (iNOS) expression is required to control mycobacterial infection in mice (1, 9, 13, 19). However, the induction of iNOS does not lead to complete elimination of M. tuberculosis in vivo (22). In addition, Flynn et al. (11) demonstrated that M. tuberculosis reactivation occurs if the production of RNI is inhibited in a murine model of latency (11). This suggests that reactivation tuberculosis may result from the removal of host defense mechanisms, such as RNI, that keep M. tuberculosis from replicating in vivo. Consequently, it is possible that ROI and RNI may inhibit replication (bacteriostatic) but do not eradicate the bacteria (bactericidal). We decided to test this concept in vitro by using RNI and ROI susceptibility assays applied to both clinical and laboratory strains of mycobacteria.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Mycobacterial strains used in this study
|
|
|
|---|
80% compared to the same strains not exposed to ASN. At day 50, however, the percent survival of all of the clinical strains exceeded 80% (Fig. 1A). Compared to the laboratory strain H37Ra, at 3 mM ASN all of the clinical strains of M. tuberculosis and M. bovis (Ravenel and BCG) were significantly more resistant at day 21 or 50 of incubation (P < 0.05, Student t test) (Fig. 1B and Table 2). In addition, at 3 mM ASN the percent survival at day 21 versus that at day 50 was significantly different for each strain. On the other hand, at a higher concentration of ASN (6 mM), the percent survival of the strains at days 21 and 50 showed no significant difference, except for H37Ra and M. bovis Ravenel (Fig. 1B). At 6 mM ASN all of the strains, except M. bovis BCG, remained relatively resistant compared to H37Ra (Table 2).
![]() View larger version (69K): [in a new window] |
FIG. 1. Mycobacterial ASN susceptibility assays. Mycobacterial isolates were incubated for 16 h in 7H9 medium (pH 5.3) and then plated onto 7H11 agar. CFU were determined at 21 and 50 days of incubation. (A) Isolates were incubated at 37°C in 7H9 broth at pH 5.3 without NaNO2, and CFU were quantified at day 21 (shaded bars) and day 50 (hatched bars). The results are expressed as the CFU ± the standard error of the mean (SEM). (B) Isolates were exposed to 3 mM (day 21 [black diamonds] and day 50 [solid squares]) and 6 mM NaNO2 (day 21 [gray triangles] and day 50 [gray circles]). The results are expressed as the percent survival based on the CFU recovered from ASN-exposed strains relative to the CFU of unexposed strains ± the SEM. Both graphs are representative of triplicate experiments and show mean values of triplicate cultures for each strain.
|
![]() View larger version (57K): [in a new window] |
FIG. 2. Mycobacterial H2O2 susceptibility assays. Mycobacterial isolates were incubated for 16 h in 7H9 medium (pH 7.0) and then plated onto 7H11 agar. CFU were determined at 21 and 50 days of incubation. (A) Isolates were incubated at 37°C in 7H9 broth at pH 7.0 without H2O2, and CFU were quantified at day 21 (shaded bars) and day 50 (hatched bars). The results are expressed as CFU ± the SEM. (B) Isolates were exposed to 2 mM (day 21 [black diamonds] and day 50 [black squares]) and 5 mM H2O2 (day 21 [gray triangles] and day 50 [gray circles]). The results are expressed as the percent survival based on CFU recovered from strains exposed to H2O2 relative to the CFU of unexposed strains ± the SEM. Both graphs are representative of triplicate experiments and show mean values of triplicate cultures for each strain.
|
|
View this table: [in a new window] |
TABLE 2. Comparison to laboratory strain H37Ra of resistance levels of each strain to ASN and H2O2
|
|
|
|---|
Considering that most mycobacterial strains were able to recover from exposure to lower concentrations of ASN when allowed to incubate beyond 3 weeks, it appears that the time of incubation after which CFU data are analyzed is important when similar assays are used to determine mycobacterial susceptibility to any type of stress. Although all of the strains in the present study exhibited some level of recovery to low concentrations of H2O2, the differences in the percent survival between day 21 and day 50 within each strain were not statistically significant, with the exception of one strain (H37Ra). One explanation for this observation is that the concentrations of H2O2 we used are bactericidal to Mycobacterium. Another possibility may be that most strains of mycobacteria, except H37Ra, are more resistant to H2O2 at 2 mM, and thus they are able to grow within 3 weeks. Hence, the concentrations of H2O2 used in the present study may have been either too low (2 mM) or too high (5 mM) to see significant differences among all of the strains when we compared the percent survival values at days 21 and 50. These hypotheses are in accord with other studies that have demonstrated either that H2O2 is bactericidal in vitro or that M. tuberculosis is relatively resistant to the effects of H2O2 in a cell-free system (2, 16, 21). Since H37Ra has a much slower growth rate than the other strains used, the significant level of recovery seen at all concentrations of ASN and H2O2 may be a consequence of not being able to visualize the colonies until much later. We tried to minimize this effect by determining the initial CFU of H37Ra at day 26 instead of at day 21, thus allowing the organism sufficient time to grow.
Collectively, our data indicate that under the in vitro conditions used here exposure to low concentrations of ASN resulted in the stasis of most clinical isolates of M. tuberculosis. In contrast to these data, a study by Chan et al. (2) found that chemically generated RNI at concentrations of between 1.0 and 10 mM are bactericidal to M. tuberculosis in vitro (2), although it should be noted that only one strain (Erdman) was analyzed and that the incubation period after which CFU were enumerated was not clearly defined. Our results are consistent with those of Rhoades and Orme (24), who demonstrated in vitro that the antimycobacterial activity of interferon-primed macrophages was bacteriostatic rather than bactericidal (24). In addition, Rhoades and Orme found that a high concentration (10 mM) of NaNO2 was mycobactericidal in a cell-free system and that lower concentrations (0.1 to 5.0 mM) showed a range of tolerance by clinical mycobacterial isolates (24). It should be noted that the cell-free assay used in the Rhoads and Orme study, although similar, was not identical to ours. Our study exposed mycobacterial strains for 16 h as opposed to a period of 10 days, and the CFU in the Rhoades and Orme study were determined at between 3 and 4 weeks.
Despite the observed bacteriostatic effect of RNI, our results also demonstrate that some clinical M. tuberculosis isolates (CDC1551 and CB3.3) are able to resist even high concentrations of ASN or H2O2. These clinical isolates were previously shown to be associated with large outbreaks of tuberculosis and were found to exhibit high levels of resistance to RNI and H2O2 compared to other clinical isolates or laboratory strains of M. tuberculosis (6, 12, 25). These observations are consistent with numerous studies that have demonstrated strain-related differences regarding susceptibility to RNI and ROI (7, 12, 16, 17, 18, 20, 23, 24, 26), and suggest that certain strains of M. tuberculosis have evolved an enhanced level of resistance to the antibacterial mechanisms elicited by the host macrophage.
The physiologic concentrations of ROI and RNI within human macrophages in vivo are not well established, although in vitro studies have determined that ca. 3.2 nmol of NO2-/105 cells and 287 nmol of H2O2/mg of protein/h are generated from resident murine macrophages stimulated with IFN-
(5). In addition, other studies have demonstrated that between 34 and 241 nmol of nitrite/106 cells in culture supernatants of human peripheral blood monocytes infected with M. tuberculosis (17) and between 10 and 80 pmol of H2O2/µg of DNA from cells stimulated with polystyrene particles (14) are generated. Hence, the amount of ROI and RNI added in the cell-free system used in the present study is higher than that expected to be generated in vivo. Therefore, relatively resistant M. tuberculosis strains, such as CB3.3 and CDC1551, are less likely to be kept in check within the host. Consequently, one could postulate that such strains are more capable of causing active disease more readily after an initial infection than strains that are relatively susceptible to RNI and ROI. In contrast, the proliferation of RNI- and ROI-susceptible strains may be controlled as long as the host is able to maintain RNI and/or ROI expression. In the absence of these stresses, such M. tuberculosis strains may resume proliferation and cause the reactivation of disease.
While there may be multiple other host factors that contribute to bacteriostasis of M. tuberculosis in vivo, the observation of the bacteriostatic effect of RNI made in vitro, as well as the wide range of RNI and/or ROI susceptibilities of the clinical isolates, may provide new clues about the different clinical outcomes after M. tuberculosis infection.
We thank Ed Desmond, Jennifer Flood, and Lisa Pascopella at the California State Health Department and Sally Cantrell for providing C.C.13 and Thomas Shinnick for kindly providing CDC1551. We also thank Lisa Morici for technical assistance and for critical review of the manuscript.
|
|
|---|
gene-disrupted mice. J. Exp. Med. 178:2243-2247.
genes. Science 259:1739-1742.
-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138:4408-4413.[Abstract]
in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
partially reconstitutes local protective immunity. Microb. Pathol. 29:175-185.[CrossRef]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»